Lumbosacral dorsopathies: modern aspects of diagnosis and pharmacological treatment

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Lumbosacral dorsopathy is the most common diagnosis in patients with lower back pain. Issues of conservative treatment of lumbosacral dorsopathies are considered based on the analysis of scientific materials contained in large databases such as PubMed, Cochrane library, MEDLINE, and eLibrary. From all publications, 40 of the most relevant works were selected and considered in detail, and key figures and short conclusions for each work are displayed in a table. Symptoms of lumbosacral dorsopathies often have an extremely negative effect on the patient’s ability to work and quality of life; therefore, effective and prompt treatment is important. Given the complex and multifactorial pathogenesis and multitudes of options for lumbosacral dorsopathies, conservative treatment should be complex and individualized, and drugs should have a high safety profile, especially those used in the treatment of chronic diseases. These requirements are met by some nonsteroidal anti-inflammatory drugs and co-analgesics, such as chondroprotectors and B vitamins. For the treatment of acute and exacerbated lumbosacral dorsopathies, the local use of hormonal drugs, anticonvulsants, antidepressants, muscle relaxants, etc., is possible, while treatment dosage and duration should be strictly limited. The local use of hormonal drugs and hodroprotectors such as therapeutic and diagnostic blockades is justified in the absence of contraindications and availability of opportunities, which helps reduce the likelihood of systemic adverse reactions and provides greater bioavailability.

About the authors

Sergey A. Zhivolupov

Military medical academy of S.M. Kirov

Email: peroslava@yandex.ru
ORCID iD: 0000-0003-0363-102X
SPIN-code: 4627-8290
Scopus Author ID: 321638

doctor of medical sciences, professor

Russian Federation, Saint Petersburg

Evgeny Y. Kozhevnikov

Military medical academy of S.M. Kirov

Author for correspondence.
Email: kozh.evgeniy@yandex.ru
ORCID iD: 0000-0001-8016-0394
SPIN-code: 4402-6613

residency student

Russian Federation, Saint Petersburg

Igor N. Samartsev

Military medical academy of S.M. Kirov

Email: alpinaigor@mail.ru
ORCID iD: 0000-0002-7659-9756
SPIN-code: 9857-4986

doctor of medical sciences

Russian Federation, Saint Petersburg

Nariman A. Rashidov

Military medical academy of S.M. Kirov

Email: info@honestmed.ru
SPIN-code: 9793-4275

candidate of medical sciences

Russian Federation, Saint Petersburg

References

  1. Levin OS. Vertebrogenic lumbosacral radiculopathy: modern approaches to diagnostics and treatment. Ehffektivnaya farmakoterapiya. 2015;(23):40–49. (In Russ.).
  2. Odinak MM, Zhivolupov SA. Zabolevaniya i travmy perifericheskoi nervnoi sistemy. Saint-Petersburg: SpetsLit, 2009. 384 p. (In Russ.).
  3. Parfenov VA, Yakhno NN, Kukushkin ML, et al. Acute nonspecific (musculoskeletal) low back pain Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics. 2018;10:4–11. (In Russ.). doi: 10.30629/2658-7947-2019-2-5-14-20
  4. Samartsev IN, Zhivolupov SA, Nazhmudinov RZ, Yakovlev YeV. Study CAMELLIA: Comparative Evaluation of Safety and Efficacy of Aceclofenac and Meloxicam Short–Term Use in Patients with Vertebrogenic Dorsalgia. Ehffektivnaya farmakoterapiya. Nevrologiya. 2018;(3):38–49. (In Russ.). doi: 10.32863/1682-7392-2018-3-63-36-38
  5. Titova NV. Patsient s nespetsificheskoi bol'yu v nizhnei chasti spiny: algoritm diagnostiki i terapii. Russkii meditsinskii zhurnal. Meditsinskoe obozrenie. 2016;24(12):775–781. (In Russ.).
  6. Backonja M, Williams L, Miao X, et al. Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial). Pain. 2017;158(9):1802–1812. doi: 10.1097/j.pain.0000000000000983
  7. Lin JH, Chiang YH, Chen CC. Lumbar radiculopathy and its neurobiological basis. World J Anesthesiol. 2014;3(2):162–173. doi: 10.5313/wja.v3.i2.162
  8. Dahm KT, Brurberg KG, Jamtvedt G, Hagen KB. Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica. Cochrane Database Syst Rev. 2010;(6):CD007612. doi: 10.1002/14651858.CD007612.pub2
  9. Hinz B, Renner B, Brune K. Drug insight: cyclo-oxygenase-2 inhibitors-a critical appraisal. Nat Clin Pract Rheumatol. 2007;3(10):552–589. doi: 10.1038/ncprheum0619
  10. Hunter TS, Robison C, Gerbino PP. Emerging evidence in NSAID pharmacology: important considerations for product selection. Am J Manag Care. 2015;21(7):139–147.
  11. Miki K, Ikemoto T, Hayashi K, et al. Randomized open-label [corrected] non–inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain. J Orthop Sci. 2018;23(3):483–487. Corrected and republished from: J Orthop Sci. 2019;24(1):192. doi: 10.1016/j.jos.2018.02.007
  12. Plapler PG, Scheinberg MA, Ecclissato Cda C, et al. Double–blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain. Drug Des Devel Ther. 2016;10:1987–1993. doi: 10.2147/DDDT.S97756
  13. Schwartz JI, Dallob AL, Larson PJ, et al. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. J Clin Pharmacol. 2008;48(6):745–754. doi: 10.1177/0091270008317590
  14. Shin JS, Ha IH, Lee J, et al. Effects of motion style acupuncture treatment in acute low back pain patients with severe disability: a multicenter, randomized, controlled, comparative effectiveness trial. Pain. 2013;154(7):1030–1037. doi: 10.1016/j.pain.2013.03.013
  15. von Heymann WJ, Schloemer P, Timm J, Muehlbauer B. Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain: a double-blinded randomized controlled trial in comparison with diclofenac and placebo. Spine. 2013;38(7):540–548. doi: 10.1097/BRS.0b013e318275d09c
  16. Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384(9954):1586–1596. doi: 10.1016/S0140-6736(14)60805-9
  17. Ximenes A, Robles M, Sands G, Vinueza R. Valdecoxib is as efficacious as diclofenac in the treatment of acute low back pain. Clin J Pain. 2007;23(3):244–250. doi: 10.1097/AJP.0b013e31802f67c6
  18. Cloutier C, Taliano J, O'Mahony W, et al. Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study. Pain Res Manag. 2013;18(2):75–82. Corrected and republished from: Pain Res Manag. 2013;18(6):328. doi: 10.1155/2013/164609
  19. Lee JH, Lee CS, Ultracet ER Study Group. A randomized, double- blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain. Clin Ther. 2013;35(11):1830–1840. doi: 10.1016/j.clinthera.2013.09.017
  20. Rauck RL, Bookbinder SA, Bunker TR, et al. A randomized, open- label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag. 2006;2(6):325–333. doi: 10.5055/jom.2006.0048
  21. Schiphorst Preuper HR, Geertzen JH, van Wijhe M, et al. Do analgesics improve functioning in patients with chronic low back pain? An explorative triple-blinded RCT. Eur Spine J. 2014;23(4): 800–806. doi: 10.1007/s00586-014-3229-7
  22. Ivanova MA, Parfenov VA, Isaikin AI. Conservative treatment for patients with discogenic lumbosacral radiculopathy: results of a prospective follow-up. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):59–65. (In Russ.). doi: 10.14412/2074-2711-2018-3-59-65
  23. Cohen SP, Hanling S, Bicket MC, et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study. Br Med J. 2015;350:h1748. doi: 10.1136/bmj.h1748
  24. Kennedy DJ, Zheng PZ, Smuck M, et al. A minimum of 5-year follow-up after lumbar transforaminal epidural steroid injections in patients with lumbar radicular pain due to intervertebral disc herniation. Spine J. 2018;18(1):29–35. doi: 10.1016/j.spinee.2017.08.264
  25. Eskin B, Shih RD, Fiesseler FW, et al. Prednisone for emergency department low back pain: a randomized controlled trial. J Emerg Med. 2014;47(1):65–70. doi: 10.1016/j.jemermed.2014.02.010
  26. Goldberg H, Firtch W, Tyburski M, et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. JAMA. 2015;313(19):1915–1923. doi: 10.1001/jama.2015.4468
  27. Manchikanti L, Singh V, Cash KA, et al. Effect of fluoroscopically guided caudal epidural steroid or local anesthetic injections in the treatment of lumbar disc herniation and radiculitis: a randomized, controlled, double blind trial with a two-year follow-up. Pain Physician. 2012;15(4):273–286. doi: 10.36076/ppj.2012/15/273
  28. Park CH, Lee SH, Park HS. Lumbar retrodiscal versus post-ganglionic transforaminal epidural steroid injection for the treatment of lumbar intervertebral disc herniations. Pain Physician. 2011;14(4):353–360. doi: 10.36076/ppj.2011/14/353
  29. Singh JR, Cardozo E, Christolias GC. The Clinical Efficacy for Two-Level Transforaminal Epidural Steroid Injections. PM and R. 2017;9(4):377–382. doi: 10.1016/j.pmrj.2016.08.030
  30. Baron R, Martin-Mola E, Müller M, et al. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study. Pain Pract. 2015;15(5):455–470. doi: 10.1111/papr.12200
  31. Baron R, Freynhagen R, Tölle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010;150(3):420–427. doi: 10.1016/j.pain.2010.04.013
  32. Kalita J, Kohat AK, Misra UK, Bhoi SK. An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache. J Neurol Sci. 2014;342(1-2):127–132. doi: 10.1016/j.jns.2014.05.002
  33. Markman JD, Frazer ME, Rast SA, et al. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Neurology. 2015;84(3):265–272. doi: 10.1212/WNL.0000000000001168
  34. Br Brötz D, Maschke E, Burkard S, et al. Is there a role for benzodiazepines in the management of lumbar disc prolapse with acute sciatica? Pain. 2010;149(3):470–475. doi: 10.1016/j.pain.2010.02.015
  35. Friedman BW, Cisewski D, Irizarry E, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain. Ann Emerg Med. 2018;71(3):348–356.e5. doi: 10.1016/j.annemergmed.2017.09.031
  36. Danilov AB. Lechenie ostroi boli v spine: vitaminy gruppy «В» ili NPVP? Russian Medical Journal. 2010;(0):35–43. (In Russ.).
  37. Chiu CK, Low TH, Tey YS, et al. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singapore Med J. 2011;52(12):868–873.
  38. Mibielli MA, Geller M, Cohen JC, et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009;25(11):2589–2599. doi: 10.3111/13696990903246911
  39. Barulin AE, Kurushina OV. Chondroprotectors in сomplex treatment for back pain. Difficult Patient. 2014;12(3):35–38. (In Russ.).
  40. Belyaev RA. Ehffektivnost' khondroprotektornoi terapii vertebrogennykh dorsopatii. Vestnik KazNMU. 2010;(3):135–139. (In Russ.).
  41. Danilov AB, Zharkova TR, Akhmetdzhanova LT. Anal'geticheskie svoistva preparata Alflutop v lechenii khronicheskoi boli v spine. Prilozhenie k zhurnalu Consilium medicum. 2010;(2):56–59. (In Russ.).
  42. Kaishibayeva G. Effectiveness of the drug Alflutop in patients with vertebral pathology. Herald of Almaty State Institute of Advanced Medical Education. 2012;(4):59–62. (In Russ.).
  43. Koval'chuk VV. Primenenie preparata Alflutop kak vozmozhnost' povysheniya ehffektivnosti traditsionnoi terapii bol'nykh, stradayushchikh bolyami v spine. Russian Medical Journal. 2014;22(10):777–781. (In Russ.).
  44. Kurganova YuM, Danilov AB. Melatonin in the treatment of low back pain and predictors of its efficacy. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(10):49–54. (In Russ.). doi: 10.17116/jnevro201711710149-54
  45. Morozova OH, Yaroshevskyi OA, Lipinska YV. The effectiveness of Arthrida® in lower back pain. International Neurological Journal. 2018;(6):37–43. (In Russ.).
  46. Yaroshevskiy AA. Analysis of the use of chondroprotectors in complex therapy of vertebrogenic dorsalgia. International Neurological Journal. 2014;(1):75–81. (In Russ.). doi: 10.22141/2224-0713.1.63.2014.80447
  47. Farajirad S, Behdani F, Hebrani P, Farajirad M. Comparison Between the Effects of Amitriptyline and Bupropione on the Quality of Life and the Reduction in the Severity of Pain in Patients With Chronic Low-Back Pain. Neurosurgery Quarterly. 2013;23(4):227–229. doi: 10.1097/WNQ.0b013e3182817d55
  48. Mazza M, Mazza O, Pazzaglia C, et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother. 2010;11(7):1049–1052. doi: 10.1517/14656561003730413
  49. Skljarevski V, Zhang S, Desaiah D, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain. 2010;11(12):1282–1290. doi: 10.1016/j.jpain.2010.03.002

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Zhivolupov S.A., Kozhevnikov E.Y., Samartsev I.N., Rashidov N.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies